Germline Genetic Testing, Counseling Move Remote as Pandemic Limits In-Person Care Capacity

Mar 24, 2020

|

NEW YORK – Many healthcare systems in recent weeks have had to shift available resources and in-person care plans to increase capacity for a potential influx of SARS-CoV-2 infected patients.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.

Menu

Germline Genetic Testing, Counseling Move Remote as Pandemic Limits In-Person Care Capacity

To read the full story....

Breaking News

Breast Cancer Subtypes Vary With Indigenous Ancestry in Latin American Women

VBL Therapeutics, NanoCarrier to Expand Clinical Trial of Ovarian Cancer Drug to Japan

BeiGene, Zymeworks Dose First Patient in Phase IB/II Trial for HER2-Positive Cancers

Pancreatic Cancers With TP53 Mutations More Sensitive to Adjuvant Chemo, Study Shows

Mutations in PTEN, ESR1 Promote Piqray Resistance in HR-Positive Breast Cancer, Study Finds

OSE Immunotherapeutics Meets Primary Endpoint in Phase III Trial for HLA-A2 Positive Lung Cancer

Featured White Papers

What's Popular?

Breast Cancer Subtypes Vary With Indigenous Ancestry in Latin American Women

Full BRCA1 Gene Deletion Suspected to Contribute to Patient's Long PARP Inhibitor Response

Metastatic Prostate Cancer Features Linked to Immunotherapy Response, Despite Low TMB

Mutations in PTEN, ESR1 Promote Piqray Resistance in HR-Positive Breast Cancer, Study Finds

BeiGene, Zymeworks Dose First Patient in Phase IB/II Trial for HER2-Positive Cancers

Sponsorships